OMNIBUS WARRANT AMENDMENT AGREEMENTOmnibus Warrant Amendment Agreement • June 20th, 2024 • Vapotherm Inc • Surgical & medical instruments & apparatus • New York
THIS OMNIBUS WARRANT AMENDMENT AGREEMENT (this “Agreement”), dated as of June 17, 2024, is entered into by and among (i) Vapotherm, Inc., a Delaware corporation (the “Company”), and (ii) each of the persons identified as a Holder on the signature pages hereto (each, a “Holder” and collectively, the “Holders”).
REGENERX BIOPHARMACEUTICALS, INC. OMNIBUS WARRANT AMENDMENT AGREEMENTOmnibus Warrant Amendment Agreement • January 7th, 2011 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Omnibus Warrant Amendment Agreement (the “Amendment”) is made effective as of January 5, 2011, by and among RegeneRx Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), Defiante Farmaceutica S.A. (“Defiante”), Taufin International S.A. (“Taufin”), as successor in interest to Inverlochy-Consultadoria e Servicos (S.U.) LDA (“Inverlochy”), and Sinaf S.A. (“Sinaf”), as successor in interest to Chaumiere-Consultadoria e Servicos SDC Unipessoal LDA (“Chaumiere”). Defiante, Taufin and Sinaf are referred to collectively herein as the “Holders”.
